Japanese Phase Ib/II Copanlisib in Relapsed, Indolent B-cell NHL

Clinical trial NCT02342665 · COMPLETED

Trial details

NCT number: NCT02342665
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Lymphoma Non-Hodgkin

Start date: 2015-04-21
Primary completion: 2018-09-14
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.